Literature DB >> 34116656

SNX10 and PTGDS are associated with the progression and prognosis of cervical squamous cell carcinoma.

Pinping Jiang1, Ying Cao2, Feng Gao3, Wei Sun1, Jinhui Liu1, Ziyan Ma4, Manxin Xie5, Shilong Fu6.   

Abstract

BACKGROUND: Cervical cancer (CC) is the primary cause of death in women. This study sought to investigate the potential mechanism and prognostic genes of CC.
METHODS: We downloaded four gene expression profiles from GEO. The RRA method was used to integrate and screen differentially expressed genes (DEGs) between CC and normal samples. Functional analysis was performed by clusterprofiler. We built PPI network by Search Tool for the Retrieval of Interacting Genes Database (STRING) and selected hub modules via Molecular COmplex Detection (MCODE). CMap database was used to find molecules with therapeutic potential for CC. The hub genes were validated in GEO datasets, Gene Expession Profiling Interactive Analysis (GEPIA), immunohistochemistry, Cox regression analysis, TCGA methylation analysis and ONCOMINE were carried out. ROC curve analysis and GSEA were also performed to describe the prognostic significance of hub genes.
RESULTS: Functional analysis revealed that 147 DEGs were significantly enriched in binding, cell proliferation, transcriptional activity and cell cycle regulation. PPI network screened 30 hub genes, with CDK1 having the strongest connectivity with CC. Cmap showed that apigenin, thioguanine and trichostatin A might be used to treat CC(P < 0.05). Eight genes (APOD, CXCL8, MMP1, MMP3, PLOD2, PTGDS, SNX10 and SPP1) were screened out through GEPIA. Of them, only PTGDS and SNX10 had not appeared in previous studies about CC. The validation in GEO showed that PTGDS showed low expression while SNX10 presented high expression in tumor tissues. Their expression profiles were consistent with the results in immunohistochemistry. ROC curve analysis indicated that the model had a good diagnostic efficiency (AUC = 0.738). GSEA analysis demonstrated that the two genes were correlated with the chemokine signaling pathway (P < 0.05). TCGA methylation analysis showed that patients with lowly-expressed and highly-methylated PTGDS had a worse prognosis than those with highly-expressed and lowly-methylated PTGDS (p = 0.037). Cox regression analysis showed that SNX10 and PTGDS were independent prognostic indicators for OS among CC patients (P = 0.007 and 0.003).
CONCLUSIONS: PTGDS and SNX10 showed abnormal expression and methylation in CC. Both genes might have high prognostic value of CC patients.

Entities:  

Keywords:  Cervical squamous cell carcinoma; Methylation; PTGDS; Prognosis; Risk model; SNX10

Year:  2021        PMID: 34116656     DOI: 10.1186/s12885-021-08212-w

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  41 in total

1.  clusterProfiler: an R package for comparing biological themes among gene clusters.

Authors:  Guangchuang Yu; Li-Gen Wang; Yanyan Han; Qing-Yu He
Journal:  OMICS       Date:  2012-03-28

Review 2.  The Connectivity Map: a new tool for biomedical research.

Authors:  Justin Lamb
Journal:  Nat Rev Cancer       Date:  2007-01       Impact factor: 60.716

3.  Comprehensive analysis of microRNA expression profile in malignant glioma tissues.

Authors:  Monika Piwecka; Katarzyna Rolle; Agnieszka Belter; Anna Maria Barciszewska; Marek Żywicki; Marcin Michalak; Stanisław Nowak; Mirosława Z Naskręt-Barciszewska; Jan Barciszewski
Journal:  Mol Oncol       Date:  2015-03-25       Impact factor: 6.603

Review 4.  A systematic review of the supportive care needs of women living with and beyond cervical cancer.

Authors:  Roma Maguire; Grigorios Kotronoulas; Mhairi Simpson; Catherine Paterson
Journal:  Gynecol Oncol       Date:  2014-11-20       Impact factor: 5.482

5.  limma powers differential expression analyses for RNA-sequencing and microarray studies.

Authors:  Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

Review 6.  Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives.

Authors:  Margherita Nannini; Maria Abbondanza Pantaleo; Alessandra Maleddu; Annalisa Astolfi; Serena Formica; Guido Biasco
Journal:  Cancer Treat Rev       Date:  2008-12-09       Impact factor: 12.111

7.  Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion.

Authors:  Yali Zhai; Rork Kuick; Bin Nan; Ichiro Ota; Stephen J Weiss; Cornelia L Trimble; Eric R Fearon; Kathleen R Cho
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

8.  MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study.

Authors:  W Patricia Bandettini; Peter Kellman; Christine Mancini; Oscar Julian Booker; Sujethra Vasu; Steve W Leung; Joel R Wilson; Sujata M Shanbhag; Marcus Y Chen; Andrew E Arai
Journal:  J Cardiovasc Magn Reson       Date:  2012-11-30       Impact factor: 5.364

9.  Profiling of Discrete Gynecological Cancers Reveals Novel Transcriptional Modules and Common Features Shared by Other Cancer Types and Embryonic Stem Cells.

Authors:  Kalliopi I Pappa; Alexander Polyzos; Jasmine Jacob-Hirsch; Ninette Amariglio; George D Vlachos; Dimitrios Loutradis; Nicholas P Anagnou
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

10.  Expression Atlas update--a database of gene and transcript expression from microarray- and sequencing-based functional genomics experiments.

Authors:  Robert Petryszak; Tony Burdett; Benedetto Fiorelli; Nuno A Fonseca; Mar Gonzalez-Porta; Emma Hastings; Wolfgang Huber; Simon Jupp; Maria Keays; Nataliya Kryvych; Julie McMurry; John C Marioni; James Malone; Karine Megy; Gabriella Rustici; Amy Y Tang; Jan Taubert; Eleanor Williams; Oliver Mannion; Helen E Parkinson; Alvis Brazma
Journal:  Nucleic Acids Res       Date:  2013-12-04       Impact factor: 16.971

View more
  3 in total

1.  Prostanoid Signaling in Cancers: Expression and Regulation Patterns of Enzymes and Receptors.

Authors:  Pavel V Ershov; Evgeniy O Yablokov; Leonid A Kaluzhskiy; Yuri V Mezentsev; Alexis S Ivanov
Journal:  Biology (Basel)       Date:  2022-04-13

2.  Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer.

Authors:  Md Selim Reza; Md Harun-Or-Roshid; Md Ariful Islam; Md Alim Hossen; Md Tofazzal Hossain; Shengzhong Feng; Wenhui Xi; Md Nurul Haque Mollah; Yanjie Wei
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

3.  Metadata analysis to explore hub of the hub-genes highlighting their functions, pathways and regulators for cervical cancer diagnosis and therapies.

Authors:  Md Selim Reza; Md Alim Hossen; Md Harun-Or-Roshid; Mst Ayesha Siddika; Md Hadiul Kabir; Md Nurul Haque Mollah
Journal:  Discov Oncol       Date:  2022-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.